{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:17:49Z","timestamp":1790630269826,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.semarthrit.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T02:11:53Z","timestamp":1539569513000},"page":"1133-1141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-3314","authenticated-orcid":false,"given":"Lazaros I.","family":"Sakkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Daoussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Mavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatis-Nick","family":"Liossis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9697-7902","authenticated-orcid":false,"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2018.10.007_bib0001","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0002","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10-producing B cells","volume":"197","author":"Mauri","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0003","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.coi.2010.10.009","article-title":"Regulation of immunity and autoimmunity by B cells","volume":"22","author":"Mauri","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0004","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2018.10.007_bib0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar3907","article-title":"IL-10-producing regulatory B cells (B10 cells) in autoimmune disease","volume":"15","author":"Kalampokis","year":"2013","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0006","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0007","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/08820139.2014.917096","article-title":"Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis","volume":"43","author":"Zheng","year":"2014","journal-title":"Immunol Invest"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0008","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0009","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ajpath.2012.03.010","article-title":"IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation","volume":"180","author":"Yang","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0010","doi-asserted-by":"crossref","first-page":"12598","DOI":"10.1523\/JNEUROSCI.1994-16.2016","article-title":"Regulatory B cells induce formation of IL-10-expressing T cells in mice with autoimmune neuroinflammation","volume":"36","author":"Pennati","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0011","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood-2012-11-465658","article-title":"Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease","volume":"121","author":"Le Huu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0012","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature11501","article-title":"Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0013","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/acel.12114","article-title":"An age-related numerical and functional deficit in CD19(+) CD24(hi) CD38(hi) B cells is associated with an increase in systemic autoimmunity","volume":"12","author":"Duggal","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0014","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1182\/blood-2004-11-4284","article-title":"Identification and characterization of circulating human transitional B cells","volume":"105","author":"Sims","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clim.2007.11.013","article-title":"Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation","volume":"127","author":"Marie-Cardine","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0016","doi-asserted-by":"crossref","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0017","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.38666","article-title":"Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity","volume":"66","author":"Daien","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0018","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"van de Veen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0019","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellimm.2012.01.007","article-title":"CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses","volume":"274","author":"Zhang","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0020","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1082703","article-title":"Phenotypic and functional characteristics of CD39(high) human regulatory B cells (Breg)","volume":"5","author":"Figueiro","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0021","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0022","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jaci.2015.09.014","article-title":"In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles","volume":"137","author":"Simon","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0023","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2014-04-571125","article-title":"Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD","volume":"124","author":"Khoder","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0024","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.39437","article-title":"Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis","volume":"68","author":"Mavropoulos","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.molimm.2014.05.018","article-title":"IL-10 production by B cells is differentially regulated by immune-mediated and infectious stimuli and requires p38 activation","volume":"62","author":"Mion","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0026","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/eji.201344341","article-title":"TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells","volume":"44","author":"Liu","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0027","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4049\/jimmunol.1600218","article-title":"Induction and differentiation of IL-10-producing regulatory B cells from healthy blood donors and rheumatoid arthritis patients","volume":"198","author":"Banko","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0028","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2016.06.002","article-title":"A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cells","volume":"73","author":"Hua","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0029","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3389\/fimmu.2017.00768","article-title":"Impairment of granzyme B-producing regulatory B cells correlates with exacerbated rheumatoid arthritis","volume":"8","author":"Xu","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0030","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/rheumatology\/ker178","article-title":"Knocking out of CD38 accelerates development of a lupus-like disease in lpr mice","volume":"50","author":"Viegas","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0031","doi-asserted-by":"crossref","first-page":"e33534","DOI":"10.1371\/journal.pone.0033534","article-title":"Mice deficient in CD38 develop an attenuated form of collagen type II-induced arthritis","volume":"7","author":"Postigo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0032","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.4049\/jimmunol.0900270","article-title":"The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals","volume":"182","author":"Yanaba","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0033","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/intimm\/dxv046","article-title":"Regulatory B10 cell development and function","volume":"27","author":"Lykken","year":"2015","journal-title":"Int Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0034","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.172.6.3422","article-title":"Distinct profiles of human B cell effector cytokines: a role in immune regulation?","volume":"172","author":"Duddy","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaut.2014.01.032","article-title":"IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut","volume":"50","author":"Sattler","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0036","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.4049\/jimmunol.0902551","article-title":"Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells","volume":"184","author":"Yang","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0037","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0038","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0039","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","article-title":"A case for regulatory B cells","volume":"176","author":"Mizoguchi","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2119\/molmed.2011.00333","article-title":"Multiple mechanisms of immune suppression by B lymphocytes","volume":"18","author":"Klinker","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0041","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12026-018-8998-3","article-title":"IL-35: a new immunomodulator in autoimmune rheumatic diseases","volume":"66","author":"Sakkas","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0042","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.jid.2017.07.843","article-title":"The unknown aspect of BAFF: inducing IL-35 production by a CD5(+)CD1d(hi)FcgammaRIIb(hi) regulatory B-cell subset in lupus","volume":"137","author":"Zhang","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0043","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI2250","article-title":"Role of interleukin 10 in specific immunotherapy","volume":"102","author":"Akdis","year":"1998","journal-title":"J Clin Investig"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0044","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/all.12966","article-title":"High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers","volume":"72","author":"Boonpiyathad","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0045","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0046","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/ncomms6997","article-title":"PD-L1hi B cells are critical regulators of humoral immunity","volume":"6","author":"Khan","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0047","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1073\/pnas.1109173109","article-title":"A tolerogenic role for toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells","volume":"109","author":"Miles","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0048","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/nm.3680","article-title":"Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production","volume":"20","author":"Rosser","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0049","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/intimm\/dxv038","article-title":"The expanding family of regulatory B cells","volume":"27","author":"Mauri","year":"2015","journal-title":"Int Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0050","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0051","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/imm.12701","article-title":"Foxd3 suppresses interleukin-10 expression in B cells","volume":"150","author":"Zhang","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0052","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2012-202352","article-title":"Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis","volume":"72","author":"Croia","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0053","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38726","article-title":"Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjogren's syndrome","volume":"66","author":"Croia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0054","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.autrev.2014.08.012","article-title":"Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment","volume":"13","author":"Sakkas","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0055","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar3736","article-title":"Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis","volume":"14","author":"Carter","year":"2012","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0056","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis","volume":"178","author":"Evans","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0057","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molimm.2017.07.001","article-title":"Methotrexate, combined with cyclophosphamide attenuates murine collagen induced arthritis by modulating the expression level of Breg and DCs","volume":"90","author":"Fan","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0058","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/eji.201546248","article-title":"MZ B cells migrate in a T-bet dependent manner and might contribute to the remission of collagen-induced arthritis by the secretion of IL-10","volume":"46","author":"Huber","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0059","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00011-015-0846-5","article-title":"Kinetic changes of regulatory B10 cells in collagen-induced arthritis could be regulated by cytokines IFN-gamma and TGF-beta1","volume":"64","author":"Zheng","year":"2015","journal-title":"Inflamm Res"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10067-013-2359-3","article-title":"Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis","volume":"33","author":"Ma","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0061","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10238-014-0310-9","article-title":"Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity","volume":"15","author":"Cui","year":"2015","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0062","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.3892\/mmr.2015.3927","article-title":"Characteristics of regulatory B10 cells in patients with rheumatoid arthritis with different disease status","volume":"12","author":"Zheng","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0063","first-page":"471","article-title":"Changes in peripheral CD19(+)Foxp3(+) and CD19(+)TGFbeta(+) regulatory B cell populations in rheumatoid arthritis patients with interstitial lung disease","volume":"7","author":"Guo","year":"2015","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0064","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3349\/ymj.2014.55.5.1354","article-title":"Regulatory B cells are inversely associated with disease activity in rheumatoid arthritis","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clim.2017.05.012","article-title":"Regulatory B cells in rheumatoid arthritis: alterations in patients receiving anti-TNF therapy","volume":"184","author":"Banko","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0066","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13075-017-1244-x","article-title":"Th17 and CD24(hi)CD27(+) regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis","volume":"19","author":"Salomon","year":"2017","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0067","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/eji.201545784","article-title":"Hypoxia-inducible factor-1alpha perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis","volume":"46","author":"Hu","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0068","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2016.09.002","article-title":"Pathogenic conversion of regulatory B10 cells into osteoclast-priming cells in rheumatoid arthritis","volume":"76","author":"Hu","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0069","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0070","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/art.34364","article-title":"Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis","volume":"64","author":"Cantaert","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0071","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180726","article-title":"Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naive for biological agents","volume":"12","author":"Bautista-Caro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0072","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/dna.2015.3046","article-title":"Defective function of CD24CD38 regulatory B cells in ankylosing spondylitis","volume":"35","author":"Chen","year":"2016","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0073","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","article-title":"Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 axis data","volume":"16","author":"Sakkas","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0074","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2017.04.010","article-title":"IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNgamma-producing T cells","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1189\/jlb.1112562","article-title":"Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation","volume":"94","author":"Yanaba","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0076","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.20010956","article-title":"Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells","volume":"195","author":"Kita","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0077","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11926-017-0707-z","article-title":"B cell-based treatments in SLE: past experience and current directions","volume":"19","author":"Liossis","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0078","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T cell signaling and subsets in systemic lupus erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0079","doi-asserted-by":"crossref","first-page":"i55","DOI":"10.1093\/rheumatology\/kew427","article-title":"Pathways leading to an immunological disease: systemic lupus erythematosus","volume":"56","author":"Zharkova","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0080","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.4049\/jimmunol.0902385","article-title":"Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity","volume":"184","author":"Watanabe","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0081","doi-asserted-by":"crossref","first-page":"e12664","DOI":"10.1111\/sji.12664","article-title":"CD38 protein deficiency induces autoimmune characteristics and its activation enhances IL-10 production by regulatory B cells","volume":"87","author":"Dominguez-Pantoja","year":"2018","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0082","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molimm.2017.02.002","article-title":"B cell activating factor (BAFF) selects IL-10(-)B cells over IL-10(+)B cells during inflammatory responses","volume":"85","author":"Ma","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0083","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molimm.2016.01.011","article-title":"Pre-existing CD19-independent GL7(-) Breg cells are expanded during inflammation and in mice with lupus-like disease","volume":"71","author":"Wang","year":"2016","journal-title":"Mol Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0084","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.1102456","article-title":"B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL. Fas(lpr) mice","volume":"188","author":"Teichmann","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cei.12639","article-title":"Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)\/lpr mice","volume":"181","author":"Cai","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0086","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3727\/096368914X685645","article-title":"Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus","volume":"24","author":"Park","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0087","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1191\/0961203303lu338oa","article-title":"Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells","volume":"12","author":"Amel Kashipaz","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0088","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaut.2004.10.001","article-title":"IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus","volume":"23","author":"Diaz-Alderete","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0089","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.3892\/mmr.2017.7381","article-title":"Expression of CD19+CD24highCD38high B cells, IL10 and IL10R in peripheral blood from patients with systemic lupus erythematosus","volume":"16","author":"Wang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0090","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jaci.2015.09.014","article-title":"In-depth characterization of CD24CD38 transitional human B cells reveals different regulatory profiles","volume":"137","author":"Simon","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0091","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/254245","article-title":"The expansion of CD25(high)IL-10(high)FoxP3(high) B regulatory cells is in association with SLE disease activity","volume":"2015","author":"Vadasz","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0092","doi-asserted-by":"crossref","first-page":"e88441","DOI":"10.1371\/journal.pone.0088441","article-title":"T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0093","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3899\/jrheum.131025","article-title":"Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus","volume":"41","author":"Wang","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0094","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3109\/03009742.2015.1126346","article-title":"Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients","volume":"45","author":"Heinemann","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0095","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/art.38742","article-title":"Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus","volume":"66","author":"Gao","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0096","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0097","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13075-015-0686-2","article-title":"Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-alpha, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients","volume":"17","author":"Fleischer","year":"2015","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0098","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/ar4571","article-title":"B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjogren's syndrome: the similarities and differences","volume":"16","author":"Lin","year":"2014","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0099","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/sji.12224","article-title":"Differential cytokine expression and regulatory cells in patients with primary and secondary Sjogren's syndrome","volume":"80","author":"Furuzawa-Carballeda","year":"2014","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0100","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4328372","article-title":"Increased IL-21 expression induces granzyme B in peripheral CD5(+) B cells as a potential counter-regulatory effect in primary Sjogren's syndrome","volume":"2016","author":"Papp","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0101","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1189\/jlb.1012525","article-title":"The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis","volume":"94","author":"Schreiber","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0102","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.semnephrol.2013.08.006","article-title":"Complement in ANCA-associated vasculitis","volume":"33","author":"Charles Jennette","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0103","doi-asserted-by":"crossref","unstructured":"Tacnet-Delorme P, Gabillet J, Chatfield S, Thieblemont N, Frachet P, Witko-Sarsat V. Proteinase 3 Interferes With C1q-Mediated Clearance of Apoptotic Cells. Front Immunol. 2018 Apr 25;9:818. doi: 10.3389\/fimmu.2018.00818.eCollection 2018. PubMed PMID: 29755460; PubMed Central PMCID: PMC5932363.","DOI":"10.3389\/fimmu.2018.00818"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0104","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar3362","article-title":"T-helper cells as new players in ANCA-associated vasculitides","volume":"13","author":"Abdulahad","year":"2011","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0105","doi-asserted-by":"crossref","first-page":"E2615","DOI":"10.1073\/pnas.1210147109","article-title":"The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis","volume":"109","author":"Ooi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0106","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1186\/ar4066","article-title":"Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy","volume":"14","author":"Wilde","year":"2012","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0107","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/annrheumdis-2012-202986","article-title":"Regulatory B cells in ANCA-associated vasculitis","volume":"72","author":"Wilde","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0108","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cei.12483","article-title":"Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies","volume":"180","author":"Aybar","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0109","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/rheumatology\/keu136","article-title":"Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"53","author":"Todd","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0110","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/rheumatology\/keu149","article-title":"Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission","volume":"53","author":"Lepse","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0111","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.autrev.2017.10.009","article-title":"New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura)","volume":"16","author":"Heineke","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0112","article-title":"A lower proportion of regulatory B cells in patients with Henoch-Schoenlein purpura nephritis","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0113","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12026-016-8877-8","article-title":"Effect of CD40\/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schonlein purpura nephritis","volume":"65","author":"Yang","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0114","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s40674-016-0043-x","article-title":"Giant cell arteritis: from pathogenesis to therapeutic management","volume":"2","author":"Watanabe","year":"2016","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0115","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/art.38625","article-title":"Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica","volume":"66","author":"van der Geest","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0116","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0117","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncprheum0346","article-title":"Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis","volume":"2","author":"Sakkas","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1346-8138.2009.00763.x","article-title":"B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis","volume":"37","author":"Hasegawa","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0119","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/ar4392","article-title":"B cells tell scleroderma fibroblasts to produce collagen","volume":"15","author":"Daoussis","year":"2013","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","article-title":"Systemic sclerosis: New evidence re-enforces the role of B cells","volume":"15","author":"Sakkas","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0121","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","article-title":"Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study","volume":"49","author":"Daoussis","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0122","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fimmu.2017.00053","article-title":"B cell homeostasis and functional properties are altered in an hypochlorous acid-induced murine model of systemic sclerosis","volume":"8","author":"Sanges","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0123","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/kev331","article-title":"Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity","volume":"55","author":"Matsushita","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0124","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2015.00496","article-title":"Systemic sclerosis patients present alterations in the expression of molecules involved in B-cell regulation","volume":"6","author":"Soto","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2017.04.013","article-title":"IL-10-producing regulatory B cells (B10 cells), IL-17+ T cells and autoantibodies in systemic sclerosis","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13075-016-1213-9","article-title":"TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients","volume":"19","author":"Aravena","year":"2017","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0127","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/art.39748","article-title":"Review: hematopoietic stem cell transplantation for scleroderma: effective immunomodulatory therapy for patients with pulmonary involvement","volume":"68","author":"Sullivan","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0128","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/bloodadvances.2017011072","article-title":"Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients","volume":"2","author":"Arruda","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0129","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00296-018-4076-3","article-title":"Decreased CD22 expression and intracellular signaling aberrations in B cells of patients with systemic sclerosis","volume":"38","author":"Melissaropoulos","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2249.2009.04059.x","article-title":"Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis","volume":"159","author":"Odaka","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0131","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrrheum.2014.95","article-title":"Autoimmunity: regulatory B cells\u2013IL-35 and IL-21 regulate the regulators","volume":"10","author":"Tedder","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0132","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41467-017-00838-4","article-title":"IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease","volume":"8","author":"Dambuza","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0133","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4252\/wjsc.v8.i9.268","article-title":"Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes","volume":"8","author":"Ma","year":"2016","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.semarthrit.2018.10.007_bib0134","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"J Allergy Clin Immunol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218304955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218304955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:58:49Z","timestamp":1758733129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017218304955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":134,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0049017218304955"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.007","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}